To test this hypothesis, we analyzed circulating activin A, follistatin and FSTL3 levels in a well-characterized cohort of pregnant women with GDM and in their normal glucose tolerance (NGT) counterparts. The gene discussed is FSTL3; the disease is gestational diabetes.